Aktiesnakken — November 2010
-
Spectrum Pharmaceuticals receives $977,900 grant under QTDP program
Spectrum Pharmaceuticals, Inc. a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that it has been awarded grants totaling $977,900 under the Qualifying Therapeutic Discovery Project (QTDP) Program administered under section 48D of the Internal Revenue Code.
News-Medical (www.news-medical.net)
-
kom du ind i columbus op til regnskab mads?
-
der er tid...
-
ved ikke om det her har været omtalt før, men det ser meget alvorligt ud http://epn.dk/investor/investering/article2235351.ece
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind